Brief: Havn Life Secures Purchase Order For Controlled Substance Sale To Revive Therapeutics Ltd
24/02/2022 13:43
Feb 24 (Reuters) - HAVN Life Sciences Inc HAVN.CD :
* HAVN LIFE SECURES PURCHASE ORDER FOR CONTROLLED SUBSTANCE
SALE
TO REVIVE THERAPEUTICS LTD. FOR USE IN CLINICAL RESEARCH
Source text for Eikon: ID:nCNWJTPl2a
Further company coverage: HAVN.CD
((reuters.briefs@thomsonreuters.com;))
Recent news on HAVN Life Sciences
See all newsBrief: Havn Life Provides Corporate Update
Brief: Havn Life Announces Financing Commitment Of C$9 Mln Through Issuance Of Convertible Debentures And Warrants
Brief: Havn Life Announces CAD$2,000,000 Private Placement With U.S. Institutional Investors
Brief: Havn Life Secures Purchase Order For Controlled Substance Sale To Revive Therapeutics Ltd
Brief: Havn Life Sciences Announces $5 Million Bought Deal Financing